Sueda T - Search Results

1

Human equilibrative nucleoside transporter 1 expression predicts survival of advanced cholangiocarcinoma patients treated with gemcitabine-based adjuvant chemotherapy after surgical resection.

Kobayashi H, Murakami Y, Uemura K, Sudo T, Hashimoto Y, Kondo N, Sueda T. Kobayashi H, et al. Among authors: sueda t. Ann Surg. 2012 Aug;256(2):288-96. doi: 10.1097/SLA.0b013e3182536a42. Ann Surg. 2012. PMID: 22580938

2

Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy.

Sasaki H, Murakami Y, Uemura K, Sudo T, Hashimoto Y, Kondo N, Sueda T. Sasaki H, et al. Among authors: sueda t. Br J Cancer. 2014 Sep 23;111(7):1275-84. doi: 10.1038/bjc.2014.399. Epub 2014 Jul 17. Br J Cancer. 2014. PMID: 25032731 Free PMC article.

3

Successful complete resection of biliary cystadenocarcinoma after percutaneous transhepatic portal embolization.

Murakami Y, Kanehiro T, Yokoyama Y, Uemura K, Sasaki M, Morifuji M, Hayashidani Y, Sudo T, Sueda T. Murakami Y, et al. Among authors: sueda t. Surgery. 2005 May;137(5):577-9. doi: 10.1016/j.surg.2003.12.006. Surgery. 2005. PMID: 15855934 No abstract available.

4

Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma.

Murakami Y, Uemura K, Ohge H, Hayashidani Y, Sudo T, Sueda T. Murakami Y, et al. Among authors: sueda t. Surgery. 2006 Sep;140(3):448-53. doi: 10.1016/j.surg.2006.03.017. Epub 2006 Jul 27. Surgery. 2006. PMID: 16934608

5

Pancreatoduodenectomy for distal cholangiocarcinoma: prognostic impact of lymph node metastasis.

Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Sueda T. Murakami Y, et al. Among authors: sueda t. World J Surg. 2007 Feb;31(2):337-42; discussion 343-4. doi: 10.1007/s00268-006-0224-0. World J Surg. 2007. PMID: 17006609

6

Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.

Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T. Murakami Y, et al. Among authors: sueda t. J Surg Oncol. 2007 Mar 1;95(3):207-12. doi: 10.1002/jso.20668. J Surg Oncol. 2007. PMID: 17278119

7

Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas.

Murakami Y, Uemura K, Hayashidani Y, Sudo T, Sueda T. Murakami Y, et al. Among authors: sueda t. J Gastrointest Surg. 2007 Mar;11(3):338-44. doi: 10.1007/s11605-006-0069-8. J Gastrointest Surg. 2007. PMID: 17458608

8

Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma.

Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Ohge H, Sueda T. Murakami Y, et al. Among authors: sueda t. J Gastrointest Surg. 2008 Mar;12(3):534-41. doi: 10.1007/s11605-007-0407-5. Epub 2007 Nov 17. J Gastrointest Surg. 2008. PMID: 18026816

9

Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer.

Hashimoto Y, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Fukuda E, Sueda T, Hiyama E. Hashimoto Y, et al. Among authors: sueda t. Surgery. 2008 Jan;143(1):113-25. doi: 10.1016/j.surg.2007.07.042. Surgery. 2008. PMID: 18154939

10

Adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma.

Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakagawa N, Ohge H, Sueda T. Murakami Y, et al. Among authors: sueda t. Am J Surg. 2008 Jun;195(6):757-62. doi: 10.1016/j.amjsurg.2007.04.018. Am J Surg. 2008. PMID: 18367131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

698 results

Search Page

Filters